Taken together, we provide a novel molecular mechanism by which oncongenic transcription factors, CREB and E2F-1, contribute to the metastatic phenotype of melanoma by negatively regulating AP-2α expression at the transcriptional level. The gene discussed is CREB1; the disease is melanoma.